Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective thyromimetics: tissue-selective thyroid hormone analogs.

T S Scanlan1, H A Yoshihara, N H Nguyen

  • 1Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California-San Francisco, San Francisco, CA 94143-0446, USA. scanlan@cgl.ucsf.edu

Current Opinion in Drug Discovery & Development
|June 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.

European review for medical and pharmacological sciences·2023
Same author

Cross-platform comparison of arbitrary quantum states.

Nature communications·2022
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons Canadian Hepato-Pancreato-Biliary Society Canadian Society of Surgical Oncology Canadian Society of Colon and Rectal Surgeons: Victoria, BC Sept. 10-13, 2009.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.

Journal of neuroimmunology·2021
Same author

Generation of thermofield double states and critical ground states with a quantum computer.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Developing selective thyromimetics offers a promising approach to target tissue-specific thyroid hormone actions. These compounds can help treat metabolic disorders by selectively modulating thyroid hormone receptor pathways.

Area of Science:

  • Endocrinology and Metabolism
  • Molecular Pharmacology

Background:

  • Thyroid hormone is crucial for development and homeostasis, with actions mediated by tissue-specific receptor isoforms.
  • Dysregulation of these tissue-specific pathways is linked to metabolic diseases.

Purpose of the Study:

  • To explore the development of synthetic thyroid hormone analogs with tissue-selective actions (selective thyromimetics).
  • To investigate the potential therapeutic applications of these selective thyromimetics in metabolic disorders.

Main Methods:

  • Utilizing tools such as receptor binding and activation assays.
  • Employing receptor structural data and thyroid hormone receptor knockout mouse models.
  • Applying medicinal chemistry approaches to design and synthesize selective thyromimetics.

Related Experiment Videos

Main Results:

  • Demonstrated that selective thyromimetics can be produced through various medicinal chemistry strategies.
  • These compounds serve as valuable probes for elucidating thyroid hormone actions.

Conclusions:

  • Selective thyromimetics represent a viable strategy for modulating tissue-specific thyroid hormone signaling.
  • These compounds hold potential for future clinical use in treating metabolic disorders.